Nova Biomedical Completes Acquisition of Assets of CCS Medical's Subsidiary, Sanvita, Inc.
Nova Biomedical Corporation, a leading developer of whole blood analyzers, today announced that the company’s independent, wholly owned subsidiary, Sanvita CBGM, LLC, has completed the acquisition of certain assets of Sanvita, Inc., a subsidiary of CCS Medical, Inc.
Read more…
Nova Biomedical and CCS Medical Reach Definitive Agreement
Nova Biomedical Corporation, a leading developer of whole blood analyzers, and CCS Medical, Inc. a leading direct-to-consumer provider of medical supplies, today announced that they have reached a definitive agreement under which Nova Biomedical’s independent, wholly owned subsidiary, Sanvita CBGM, LLC, will acquire certain assets of Sanvita, Inc., a wholly-owned subsidiary of CCS Medical. Sanvita, Inc. is currently the exclusive distributor of Nova’s “NovaMax” consumer blood glucose product line in the United States. The NovaMax blood glucose monitor has the fastest test time and absolutely no coding.
Read more…
Automated Modular Analyzer Provides Fast, Comprehensive Cell Culture Analysis
A new, automated modular analyzer from Nova Biomedical provides fast, comprehensive analysis for cell culture processing. BioProfile® FLEX provides up to 15 key cell culture attributes, including glucose, lactate, glutamine, glutamate, ammonium, PCO2, PO2, pH, sodium, potassium, calcium, osmolality, cell density/viability, and phosphate in a single, easy to use workstation.
Read more…
Nova StatStrip Glucose Analyzer Receives FDA Clearance for Neonatal Testing
Nova's new StatStrip™ Glucose Monitor has received clearance from the U.S. Food and Drug Administration for use in neonatal testing.
Read more…
First True "No Coding" Blood Glucose Monitoring System Provides Fast, Convenient Solution for Diabetes Self-Testing
An advanced blood glucose monitoring system from Nova Biomedical provides a fast, convenient solution for diabetes self-testing. The newly released Nova Max™ system is built around patented* new technology test strips that are so precise they do not require the calibration or coding required of currently available blood glucose monitors to perform a glucose test.
Read more…
"All-in-One" Stat Analyzer Adds Total Bilirubin to Test Menu
Nova Biomedical announces the incorporation of total bilirubin (tBil) to the comprehensive test menu on its Stat Profile® Critical Care Xpress (CCX) "All-in-One" Analyzers.
Read more…
Point-of-Care Blood Glucose Monitoring System Measures and Correct Hematocrit and Electrochemical Interferences
An advanced blood glucose monitoring system from Nova Biomedical elevates bedside glucose testing to a new level of analytical performance that approaches the quality of central laboratory testing.
Read more…
Novation Contract Awarded to Nova Biomedical
Nova Biomedical is pleased to announce that it has been awarded a three-year agreement to provide its multi-analyte point of care testing instrumentation to Novation, effective August 1, 2005.
Read more…
StatStrip® Glucose and StatSensor™ Creatinine Meters Now Allow Off-Line Entry of POC Test Results
A new software enhancement for Nova StatStrip® Glucose and StatSensor™ Creatinine point-of-care monitoring systems allows off-line entry of POC test results for immediate data capture.
Read more…
OPC Connectivity Suite Facilitates BioProfile® FLEX Bi-Directional Automation and Process Integration
A new Connectivity Suite from Nova Biomedical is a complete plug and play solution for use with the BioProfile® FLEX Cell Culture Analyzer that facilitates Nova's groundbreaking bi-directional automation and product integration.
Read more…
|
